THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis and diabetes, is scheduled to present at the Cambria Capital Investor Meeting in Salt Lake City on Thursday, April 9, 2009 at 3:45 p.m. MST.
